Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. | President & CEO, Director | Series A Common Stock | 639K | $3.37M | $5.27 | Mar 26, 2024 | Direct |
Sagimet Biosciences Inc. | President & CEO, Director | Stock Option (Right to Buy) | 1.01M | Jul 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMT | Sagimet Biosciences Inc. | Mar 26, 2024 | 1 | $63.7K | 4 | Mar 28, 2024 | President & CEO, Director |
SGMT | Sagimet Biosciences Inc. | Dec 7, 2023 | 1 | $6.56K | 4 | Dec 8, 2023 | President & CEO, Director |
SGMT | Sagimet Biosciences Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 21, 2023 | President & CEO, Director |
SGMT | Sagimet Biosciences Inc. | Nov 16, 2023 | 1 | $1.39K | 4 | Nov 20, 2023 | President & CEO, Director |
SGMT | Sagimet Biosciences Inc. | Jul 18, 2023 | 2 | $0 | 4 | Jul 20, 2023 | President & CEO, Director |
SGMT | Sagimet Biosciences Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | President & CEO, Director |